Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Donor Apheresis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 0 results

Early research (Phase 1)Enrolling By InvitationNCT05973734
What this trial is testing

Islet Transplantation With Recipient T-Reg Cells or Deceased Donor Vertebral Bone Marrow Therapy

Who this might be right for
Islet Transplantation
Stanford University 24
Not applicableActive Not RecruitingNCT07316829
What this trial is testing

TRAnscriptional Profile of Peripheral Blood Cells in Patient With Chronic Kidney and Lung Rejection: Correlation With Response to Extracorporeal Photo-aphereSiS

Who this might be right for
Graft RejectionKidney TransplantationLung Transplantation+6 more
Fondazione IRCCS Policlinico San Matteo di Pavia 30
Testing effectiveness (Phase 2)WithdrawnNCT05288595
What this trial is testing

TCR Alpha/Beta and CD19-deplete Haplo-HSCT

Who this might be right for
Pediatric PatientsHematologic MalignancyOther Hematologic Condition
University of Colorado, Denver
Testing effectiveness (Phase 2)Active Not RecruitingNCT03077542
What this trial is testing

Nonmyeloablative Haploidentical Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
National Heart, Lung, and Blood Institute (NHLBI) 57
Not applicableStudy completedNCT00001623
What this trial is testing

Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia

Who this might be right for
Graft vs Host DiseaseHematologic NeoplasmLeukemia+2 more
National Heart, Lung, and Blood Institute (NHLBI) 41
Testing effectiveness (Phase 2)Study completedNCT01818284
What this trial is testing

Plerixafor for Stem Cell Mobilization in Normal Donors

Who this might be right for
Blood And Marrow Transplantation
M.D. Anderson Cancer Center 22
Large-scale testing (Phase 3)Study completedNCT00005782
What this trial is testing

Mobilization and Handling of Stem Cells for Transplant From Healthy Volunteers With Sickle Cell Trait

Who this might be right for
Sickle Cell Trait
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 12
Not applicableStudy completedNCT00073060
What this trial is testing

Citrate Effects and Bone Density in Long-Term Apheresis Donors

Who this might be right for
Healthy Apheresis Donors
National Institutes of Health Clinical Center (CC) 273
Not applicableLooking for participantsNCT00001846
What this trial is testing

Collection and Distribution of Blood Components From Healthy Donors for In Vitro Research Use

Who this might be right for
Blood DonorsResearch SubjectsApheresis
National Institutes of Health Clinical Center (CC) 5,000
Post-approval studies (Phase 4)Looking for participantsNCT01553214
What this trial is testing

Improving White Blood Cell Collection From Healthy Donors

Who this might be right for
Allogeneic Granulocyte Donation
National Institutes of Health Clinical Center (CC) 1,000
Early research (Phase 1)Study completedNCT00001842
What this trial is testing

G-CSF for Granulocyte Donation

Who this might be right for
Healthy
National Institutes of Health Clinical Center (CC) 16
Not applicableStudy completedNCT00001872
What this trial is testing

Cell Selection for Bone Marrow Transplants to Prevent Graft-Versus-Host-Disease

Who this might be right for
Graft vs Host DiseaseHematologic Neoplasm
National Heart, Lung, and Blood Institute (NHLBI) 14